River Wealth Advisors LLC Bristol Myers Squibb CO Transaction History

River Wealth Advisors LLC

$740 Million
Q3 2024

A detailed history of River Wealth Advisors LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, River Wealth Advisors LLC holds 8,156 shares of BMY stock, worth $479,409. This represents 0.06% of its overall portfolio holdings.

Number of Shares

8,156

Previous 8,474 3.75%

Holding current value

$479,409

Previous $351,000 20.23%

% of portfolio

0.06%

Previous 0.05%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$39.66 - $51.75 $12,611 - $16,456	-318 Reduced 3.75%	8,156 $422,000
Q2 2024 Aug 13, 2024	BUY	$40.25 - $52.99 $32,039 - $42,180	796 Added 10.37%	8,474 $351,000
Q1 2024 May 14, 2024	BUY	$47.98 - $54.4 $160,541 - $182,022	3,346 Added 77.24%	7,678 $416,000
Q4 2023 Feb 13, 2024	SELL	$48.48 - $57.85 $100,450 - $119,865	-2,072 Reduced 32.35%	4,332 $222,000
Q3 2023 Nov 13, 2023	SELL	$57.89 - $64.73 $16,035 - $17,930	-277 Reduced 4.15%	6,404 $371,000
Q2 2023 Aug 09, 2023	SELL	$63.71 - $70.74 $2,293 - $2,546	-36 Reduced 0.54%	6,681 $427,000
Q1 2023 May 11, 2023	SELL	$65.71 - $74.53 $38,900 - $44,121	-592 Reduced 8.1%	6,717 $465,000
Q4 2022 Feb 10, 2023	SELL	$68.48 - $81.09 $2,670 - $3,162	-39 Reduced 0.53%	7,309 $525,000
Q3 2022 Nov 14, 2022	SELL	$0.13 - $76.84 $62 - $36,652	-477 Reduced 6.1%	7,348 $522,000
Q2 2022 Aug 10, 2022	SELL	$72.62 - $79.98 $29,919 - $32,951	-412 Reduced 5.0%	7,825 $603,000
Q1 2022 May 09, 2022	SELL	$61.48 - $73.72 $62,217 - $74,604	-1,012 Reduced 10.94%	8,237 $602,000
Q4 2021 Feb 11, 2022	SELL	$53.63 - $62.52 $4,397 - $5,126	-82 Reduced 0.88%	9,249 $577,000
Q3 2021 Nov 12, 2021	BUY	$59.17 - $69.31 $82,364 - $96,479	1,392 Added 17.53%	9,331 $552,000
Q2 2021 Aug 06, 2021	SELL	$61.91 - $67.42 $254,883 - $277,568	-4,117 Reduced 34.15%	7,939 $530,000
Q1 2021 May 11, 2021	BUY	$59.34 - $66.74 $93,341 - $104,982	1,573 Added 15.01%	12,056 $761,000
Q4 2020 Feb 16, 2021	BUY	$57.74 - $65.43 $11,894 - $13,478	206 Added 2.0%	10,483 $650,000
Q3 2020 Nov 10, 2020	BUY	$57.43 - $63.64 $159,655 - $176,919	2,780 Added 37.08%	10,277 $620,000
Q2 2020 Aug 11, 2020	BUY	$54.82 - $64.09 $35,194 - $41,145	642 Added 9.37%	7,497 $441,000
Q1 2020 May 05, 2020	BUY	$46.4 - $67.43 $12,528 - $18,206	270 Added 4.1%	6,855 $382,000
Q4 2019 Feb 07, 2020	BUY	$49.21 - $64.19 $324,047 - $422,691	6,585 New	6,585 $423,000
Q1 2019 May 07, 2019	SELL	$45.12 - $53.8 $38,261 - $45,622	-848 Closed	0 $0
Q4 2018 Jan 25, 2019	SELL	$48.76 - $63.23 $12,726 - $16,503	-261 Reduced 23.53%	848 $44,000
Q3 2018 Nov 09, 2018	SELL	$55.19 - $62.25 $34,548 - $38,968	-626 Reduced 36.08%	1,109 $69,000
Q2 2018 Aug 13, 2018	BUY	$50.53 - $62.98 $87,669 - $109,270	1,735 New	1,735 $96,000
Q1 2018 May 02, 2018	SELL	$59.92 - $68.98 $250,765 - $288,681	-4,185 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$59.94 - $65.35 $20,079 - $21,892	335 Added 8.7%	4,185 $256,000
Q3 2017 Nov 06, 2017	BUY	$55.23 - $63.74 $212,635 - $245,399	3,850	3,850 $245,000

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of River Wealth Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on River Wealth Advisors LLC with notifications on news.

Account

River Wealth Advisors LLC Bristol Myers Squibb CO Transaction History